1. Home
  2. KRYS vs WH Comparison

KRYS vs WH Comparison

Compare KRYS & WH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$298.90

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Logo Wyndham Hotels & Resorts Inc.

WH

Wyndham Hotels & Resorts Inc.

HOLD

Current Price

$79.47

Market Cap

6.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
WH
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
6.4B
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
KRYS
WH
Price
$298.90
$79.47
Analyst Decision
Strong Buy
Buy
Analyst Count
11
10
Target Price
$297.60
$94.10
AVG Volume (30 Days)
273.5K
1.0M
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
2.04%
EPS Growth
128.00
N/A
EPS
1.83
0.80
Revenue
$389,130,000.00
$1,429,000,000.00
Revenue This Year
$38.74
$6.86
Revenue Next Year
$32.53
$5.83
P/E Ratio
$166.58
$100.81
Revenue Growth
33.94
1.49
52 Week Low
$123.03
$69.21
52 Week High
$319.48
$92.69

Technical Indicators

Market Signals
Indicator
KRYS
WH
Relative Strength Index (RSI) 55.98 42.47
Support Level $253.89 $70.82
Resistance Level $319.48 $82.13
Average True Range (ATR) 11.79 2.59
MACD -0.87 -0.28
Stochastic Oscillator 46.86 27.62

Price Performance

Historical Comparison
KRYS
WH

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About WH Wyndham Hotels & Resorts Inc.

As of Dec. 31, 2025, Wyndham Hotels & Resorts operates 869,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Ramada is the largest brand, representing around 14% of all rooms, with Days Inn (13%) and Super 8 (10%) the next two largest brands, as of the end of 2025. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represented 58% of total rooms in 2025.

Share on Social Networks: